These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37649156)

  • 1. Prediction of the Peptide-TIM3 Binding Site in Inhibiting TIM3-Galectin 9 Binding Pathways.
    Odstrcil RE; Dutta P; Liu J
    J Chem Theory Comput; 2023 Sep; 19(18):6500-6509. PubMed ID: 37649156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
    Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
    Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Tim‑3 and Gal‑9 expression and gastric cancer prognosis.
    Wang Y; Zhao E; Zhang Z; Zhao G; Cao H
    Oncol Rep; 2018 Oct; 40(4):2115-2126. PubMed ID: 30106451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.
    Zhong T; Zhao C; Wang S; Tao D; Ma S; Shou C
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):783-792. PubMed ID: 33084973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema.
    Fernandez-Santamaría R; Palomares F; Salas M; Doña I; Bogas G; Ariza A; Rodriguez-Nogales A; Plaza-Seron MC; Mayorga C; Torres MJ; Fernández TD
    Allergy; 2019 Sep; 74(9):1769-1779. PubMed ID: 31034608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.
    Kandel S; Adhikary P; Li G; Cheng K
    Cancer Lett; 2021 Jul; 510():67-78. PubMed ID: 33895262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim3 binding to galectin-9 stimulates antimicrobial immunity.
    Jayaraman P; Sada-Ovalle I; Beladi S; Anderson AC; Dardalhon V; Hotta C; Kuchroo VK; Behar SM
    J Exp Med; 2010 Oct; 207(11):2343-54. PubMed ID: 20937702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis.
    Sada-Ovalle I; Chávez-Galán L; Torre-Bouscoulet L; Nava-Gamiño L; Barrera L; Jayaraman P; Torres-Rojas M; Salazar-Lezama MA; Behar SM
    J Immunol; 2012 Dec; 189(12):5896-902. PubMed ID: 23180819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological implications of TIM3
    Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
    Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylserine-Induced Conformational Modulation of Immune Cell Exhaustion-Associated Receptor TIM3.
    Weber JK; Zhou R
    Sci Rep; 2017 Oct; 7(1):13579. PubMed ID: 29051586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis.
    Feng X; Feng J
    J Clin Neurosci; 2016 Dec; 34():193-197. PubMed ID: 27544230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim3/galectin-9 alleviates the inflammation of TAO patients via suppressing Akt/NF-kB signaling pathway.
    Luo LH; Li DM; Wang YL; Wang K; Gao LX; Li S; Yang JG; Li CL; Feng W; Guo H
    Biochem Biophys Res Commun; 2017 Sep; 491(4):966-972. PubMed ID: 28756232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
    J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research Progress in the Role of Tim3/galectin-9 in Hematological Malignancy--Review].
    Yang DQ; Zhang YM; Wu LY; Wu D; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1360-1364. PubMed ID: 34362531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.
    Tembhre MK; Parihar AS; Sharma A; Gupta S; Chattopadhyay P; Sharma VK
    Immunol Res; 2015 May; 62(1):23-34. PubMed ID: 25784621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes.
    Sun L; Zou S; Ding S; Du X; Shen Y; Liu C; Shi B; Zhang X
    J Diabetes Res; 2020; 2020():2583257. PubMed ID: 33123595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.
    Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
    Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.